Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Bliss GVS Pharma Limited Board/Management Information 2021

May 11, 2021

61284_rns_2021-05-11_f9c91310-a6ee-4053-9b85-03cbfb9e6f80.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

BLISS GVS PHARMA LTD. ca.s.s

May ll, 2021

Dear Sir/Madam,

Subject: Outcome of Board Meeting held on Tuesday, May 11, 2021

We would like to inform you that, the Board Meeting of the Company was held today i.e. Tuesday, May 11, 2021 at the registered office of the Company. In pursuant to Regulation 30 and Regulation 33 read with schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board has considered and approved the following matters:

    1. The Audited standalone and consolidated financial results of the Company for the quarter and year ended March 31, 2021 along with the audit report of the auditors. The copy of said financial results and audit reports are enclosed herewith as' Annexure -1';
    1. Declaration of unmodified opinion for annual audited standalone and consolidated financial results for the year ended March 31, 2021 in accordance with Regulation 33(3)( d) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI circular no. CIR/CFD/CMD/56/2016 dated May 27, 2016 is enclosed herewith as 'Annexure - 2';
    1. Recommended Final dividend of 50% i.e. 0.50 paisa per equity share on face value of Rs. 1/ each for the financial year ended March 31, 2021, subject to approval of the shareholders in the forthcoming Annual General Meeting of the Company;
    1. Re-appointment of M/ s. BDO India LLP, Chartered Accountant having LLP registration no. AAB-7880 as Internal Auditor of the Company for the financial year 2021-22. The brief profile

Factory: Regd. Office: 102, Hyde Park, Saki Vihar Road, Andheri (East), Mumbai - 400 072, INDIA. TEL. : (+91) (22) 42160000/ 28505387 • FAX. : (+91) (22) 28563930, Email: [email protected] ·Website: www.blissgvs.com • CIN - L24230MH1984PLC034771 Plot No. 10 & 11 Survey No. 38/1, Dewan Udyog Nagar, Aliyali Village, Tai. & Dist. Palghar - 401 404. Tel. (+91) (02525) 252713 • Fax: (+91) (02525) 255257. • Email : [email protected]

  1. Issue & Allotment of 2,10,500 Equity Shares of face value of Rs. 1 each of the Company under 'Bliss GVS Pharma Limited-Employee Stock Option Plan 2019' ('Bliss GVS ESOP-2019') to the eligible employees under the said Plan, pursuant to exercise of stock options granted thereunder.

Consequent to the aforesaid allotment, Issued, subscribed & paid-up share capital of the Company has increased as under:

From To
10,31,46,672 equity shares of Re.1 each 10,33,57,172 equity shares of Re.l each
aggregating Rs. 10,31,46,672/- aggregating Rs. 10,33,57,172 / -

In terms of Regulation lO(c) of the SEBI (Share Based Employee Benefits) Regulations, 2014 (SEBI SBEB Regulations) read with SEBI Circular CIR/CFD/CMD/4/2015 dated September 9, 2015 the details of shares allotted as above are given in' Annexure-4';

    1. Re-appointment of Mr. Santosh Laxman Parab (DIN:01622988), as an Non-Executive Independent Director of the Company for a further period of 5 years with effect from 26th May, 2021 to 25th May, 2026, subject to the approval of members in the ensuing Annual General Meeting. The brief profile of Mr. Santosh Laxman Parab is enclosed herewith as 'Annexure-5';
    1. Resignation of Mr.SN Kama th from the position of Managing Director as well as membership from all conunittees of board of the Company with inunediate effect i.e. May 11, 2021;
    1. Appointment of Mr. Gagan Harsh Sharma (DIN:07939421) as Managing Director of the Company for a period of Three years with effect from 11th May, 2021 to 10th May, 2024, subject to the approval of members in the ensuing Annual General Meeting. The brief profile is enclosed herewith as' Annexure-6'.
    1. The Board reconstituted the following conunittees:
  • a. Audit Committee
  • b. Corporate Social Responsibility Committee

The Reconstitution is enclosed herewith as' Annexure -7'.

Regd. Office : 102, Hyde Park, Saki Vihar Road, Andheri (East), Mumbai - 400 072, INDIA. TEL.: (+91) (22) 42160000/ 28505387 • FAX.: (+91) (22) 28563930, Email: [email protected] •Website: www.blissgvs.com • CIN - L24230MH1984PLC034771 Factory : Plot No. 1 O & 11 Survey No. 38/1, Dewan Udyog Nagar, Aliyali Village, Tai. & Dist. Palghar - 401 404. Tel. (+91) (02525) 252713 • Fax: (+91) (02525) 255257. • Email : [email protected]

BLISS GVS PHARMA LTD.

The meeting of the Board of Directors conunenced at 12:30 p.m. and concluded at 07:20 p.m. Kindly take the above information on your record and acknowledge.

Thanking you.

Your Faithfully,

Encl: As abov For Bliss GV Pharma Limited

Factory: Regd. Office: 102, Hyde Park, Saki Vihar Road, Andheri (East}, Mumbai - 400 072, INDIA. TEL.: (+91) (22) 42160000/ 28505387 • FAX.: (+91) (22) 28563930, Email: [email protected] •Website: www.blissgvs.com • CIN - L24230MH1984PLC034771 Plot No. 10 & 11 Survey No. 38/1, Dewan Udyog Nagar, Aliyali Village, Tai. & Dist. Palghar - 401 404. Tel. (+91) (02525) 252713 • Fax: (+91) (02525} 255257. • Email :·[email protected]

'Annexure - 4'

Regulation lO(c) of the SEBI (Share Based Employee Benefits) Regulations, 2014

and
Company
Name
address
of
Bliss GVS Pharma Limited
Registered Office Add:
102, Hyde Park, Sakivihar
Road,
Andheri (East), Mumbai - 400072
Name of the Stock Exchanges on which BSE Limited
the Company's shares are listed The National
Stock Exchange
of India
Limited
Filing date of the statement referred in 14/02/2020
regulation lO(b) of the SEBI (Share Based
Benefits)
Regulations,
Employee
2014
with Stock Exchange
Filing Number, if any Application No:
BSE -106063
NSE-23188
In-Principle Approval Letter:
BSE: DCS/FL/DS/ESOP-IP /542/2019-20
dated February 27, 2020
NSE: NSE/LIST/2
dated March 04,
3188
2020
Title of the Scheme pursuant to which Pharma
Limited-Employee
Bliss
GVS
shares are issued, if any Stock Option Plan 2019
Kind of security to be listed Equity Shares
Par value of the shares Rs. 1 / - Per Share
Date of issue of shares May 11, 2021
Number of shares issued 2,10,500
Share Certificate No., if applicable Not Applicable
share,
Distinctive
number
the
if
of
applicable
to
(both
10,31,46,672
10,33,57,172
inclusive)
ISIN Number of the shares if issued in INE416D01022
Demat
Exercise price per share Rs.43 per share
Premium per share Rs.42 per share

Total Issued shares after this issue 10,33,57,172
Total Issued share capital after this issue Rs.10,33,57,172/-
Details of any lock-in on the shares Lock in for a period of 6 (six) months from
the date of allotment of Equity Shares.
Date of expiry of lock-in 10th November, 2021
Whether shares identical in all respects to All equity shares of the Company allotted
if not, when will they
shares
existing
pursuant to exercise of stock options shall
become identical? rank pari-passu with the existing equity
shares of the Company
Details of listing fees, if payable Not applicable

Relevant disclosures as per SEBI circular CIR/CFD/CMD/4/2015 dated September 9, 2015

Options Vested 690,250 Equity Shares
Time
within
which
option
be
may
Within a period of 6 (Six) months from the
exercised date of vesting of such options.
Options exercised 2,10,500 Equity Shares
Money realized by exercise of options Rs.90,51,500/-
The total number
of shares
arising
as
2,10,500 Equity Shares
result of exercise of option
Options lapsed -
per share pursuant to
Diluted earnings
Rs.6.53 per share
issue
of equity
shares
exercise
on
of
options
Whether the scheme is in terms of SEBI Yes
(SBEB) Regulations, 2014